✦ LIBER ✦

Calcitonin use in giant cell bone tumors

✍ Scribed by H. Nouri; M. Hedi Meherzi; M. Ouertatani; M. Mestiri; K. Zehi; M. Douik; M. Zouari

Book ID: 119341306
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 388 KB
Volume: 97
Category: Article
ISSN: 1877-0568
DOI: 10.1016/j.otsr.2011.03.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Giant cell tumors in combination with ot

Giant cell tumors in combination with other primary bone tumors

✍ H. J. Ruckstuhl; E. Morscher; W. Remagen; R. Ganz; X. Beffa 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 889 KB

Telomerase Activity in Giant Cell Tumors

Telomerase Activity in Giant Cell Tumors of Bone

✍ Toshihiro Matsuo; Eiso Hiyama; Takashi Sugita; Shoji Shimose; Tadahiko Kubo; Yu 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 291 KB

Chromosomal abnormalities in giant cell

Chromosomal abnormalities in giant cell tumors of bone

✍ Georgia Bardi; Nikos Pandis; Nils Mandahl; Sverre Heim; Kostas Sfikas; Helena Wi 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 303 KB

Human calcitonin has the same inhibitory

Human calcitonin has the same inhibitory effect on osteoclastic bone resorption by human giant cell tumor cells as salmon calcitonin

✍ S. Iida; S. Kakudo; M. Matsui; K. Nagahira; M. Kumegawa 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 135 KB

Malignancy in giant cell tumor of bone

✍ Franco Bertoni; Patrizia Bacchini; Eric L. Staals 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 1023 KB

## Abstract ## BACKGROUND The term __malignant giant cell tumor__ embraces multiple entities and therefore can be confusing. The goals of the current study were to define the clinicopathologic and histologic features of malignancy in giant cell tumors and to clarify the terminology. ## METHODS T

Osteoblast lineage properties in giant c

Osteoblast lineage properties in giant cell tumors of bone

✍ Atsushi Murata; Takuya Fujita; Norio Kawahara; Hiroyuki Tsuchiya; Katsuro Tomita 📂 Article 📅 2005 🏛 Springer Japan 🌐 English ⚖ 744 KB